
Friday, March 29, 2024 1:47:40 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent XERS News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2025 09:11:06 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/06/2025 09:07:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2025 12:21:40 PM
- Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025 • Business Wire • 02/27/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2025 01:09:24 PM
- Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer • Business Wire • 02/24/2025 01:00:00 PM
- Xeris to Participate in Upcoming Investor Conferences • Business Wire • 02/05/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2025 12:40:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2025 12:39:33 AM
- The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness • PR Newswire (US) • 01/21/2025 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2025 12:17:43 PM
- Xeris Expects to Exceed Full-Year 2024 Financial Guidance • Business Wire • 01/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2025 09:42:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2025 09:42:05 PM
- Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • Business Wire • 01/06/2025 09:15:00 PM
- Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference • Business Wire • 11/26/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2024 09:02:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2024 12:13:35 PM
- Xeris Biopharma Reports Third Quarter 2024 Financial Results • Business Wire • 11/08/2024 12:00:00 PM
- Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024 • Business Wire • 10/31/2024 12:00:00 PM
- Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • Business Wire • 10/04/2024 08:05:00 PM
- Xeris to Participate in Upcoming Investor Conferences • Business Wire • 08/22/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 08:06:56 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/08/2024 08:27:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:15:47 AM
FEATURED Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 • Mar 10, 2025 9:05 AM
North Bay Resources Announces Assays up to 5.69% Copper, 1 Opt. Silver, and 0.22% Vanadium at Copper Island Project, British Columbia • NBRI • Mar 10, 2025 9:00 AM
Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare • AVAI • Mar 10, 2025 8:00 AM
Veri Medtech (VRHI) Network Grows To 400 Physicians • VRHI • Mar 10, 2025 7:32 AM
One World Products' Isiah Thomas Issues Investor Update • OWPC • Mar 6, 2025 9:19 AM
Authentic Holdings To Reduce Debt by over $2 Million While Achieving Substantial Revenue Growth • AHRO • Mar 6, 2025 8:00 AM